CRA is a proud sponsor of this event.
Mario Lopez is a speaker during the webinar discussing the fundamentals and recent developments in determining FRAND royalties for SEPs.
For more information on this event, click here.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...
